News

The pharmaceutical industry is highly technical, and significant developments can rapidly transform the sector. For instance, Novo Nordisk's (NYSE: NVO) introduction of GLP-1 weight loss drugs was a

While the healthcare sector has not kept pace with broader equities so far, some industry leaders have. AbbVie (NYSE: ABBV), a pharmaceutical giant, is one of them. The company's shares are up by

Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million

Rigetti Computing (NASDAQ: RGTI) was one of the hottest quantum computing stocks in 2025, as the company hit some important hardware milestones this year. This included demonstrating the industry's

On Dec. 17, 2025, Michael Castagna, Chief Executive Officer of MannKind Corporation (NASDAQ:MNKD), executed an exercise and immediate sale of 65,804 common shares for a transaction value of

A $1,000 investment will buy you nearly 20 shares of Bristol Myers Squibb (NYSE: BMY) and about 10 shares of Medtronic (NYSE: MDT). For dividend lovers, they should both be appealing buy-and-hold

For the most part, the stock market tends to be sedate in the late holiday season. That sure wasn't the case on Wednesday with Omeros (NASDAQ: OMER), which saw a nearly 76% share price leap after

Shares of Dynavax Technologies (NASDAQ: DVAX) popped on Wednesday after the vaccine maker struck a deal to be acquired by Sanofi (NASDAQ: SNY).

As of 3:00 p.m. EST, Dynavax's stock price was up

On November 13, New York City-based Hyperion Capital Advisors disclosed a new position in Vertex (NASDAQ:VERX), acquiring 540,000 shares valued at approximately $13.39 million.

According to a filing

Shares in Agios Pharmaceuticals (NASDAQ: AGIO) soared by more than 18% as of 11 a.m. today. The move follows the company's receipt of approval from the Food and Drug Administration (FDA) for AQVESME

Novo Nordisk (NYSE:NVO), which develops and markets diabetes and obesity treatments, closed Tuesday’s session at $51.61, up 7.30% after U.S. approval of its once-daily oral Wegovy weight-loss pill

New York City-based Horizon Kinetics Asset Management disclosed a new position in WaterBridge Infrastructure LLC (NYSE:WBI), acquiring about 6.35 million shares valued at $160.26 million, per a

New York City-based Horizon Kinetics Asset Management reported a buy of 133,188 shares of LandBridge Company LLC (LB), while the position value decreased by $71.14 million, per a November 14 SEC

In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), and other AI stocks. To learn more, check out the short video, consider subscribing,

Shares of Novo Nordisk (NYSE: NVO) surged after the company introduced its GLP-1 weight loss drugs to the market. Investors correctly recognized the desirability of a weight loss drug, but, as often

Investing in dividend stocks is a proven way to grow wealth. Over the last 50 years, dividend stocks have delivered more than double the average annual total return compared to non-dividend payers,

A decade ago, Advanced Micro Devices (NASDAQ: AMD) was in a difficult position. Revenue fell 28% in 2015, primarily due to declining processor sales, and the company posted a net loss of $660

Pfizer (NYSE: PFE) and Merck (NYSE: MRK) are two pharmaceutical giants that have lagged broader equities this year. Both have delivered unimpressive financial results recently, and are facing a

B. Lynne Parshall, Director at Cytokinetics, Incorporated (NASDAQ:CYTK), reported the sale of 5,000 shares in an open-market transaction valued at ~$323,650 on November 19, 2025; direct ownership

CRISPR Therapeutics (NASDAQ: CRSP) has had a volatile performance over the past five years. While its stock is up more than 40% this year, in three of the past five years it has fallen by more than

When it comes to famous investment personalities, names such as Warren Buffett or Jamie Dimon usually get mentioned first. In the world of hedge funds, though, Ken Griffin is the cream of the crop.

Valuations for many stocks are sky-high, and that can make now an unappealing time to invest in the stock market. However, there are still some great value buys that don't involve taking on a lot of

UnitedHealth Group (NYSE: UNH) and Eli Lilly (NYSE: LLY) are two of the largest and most powerful healthcare companies in the world. One is a juggernaut that provides insurance, care services, and